retatrutide type 2 diabetes trial 2024 Availability & Timeline Lilly's triple agonist, retatrutide, demonstrated

The GLP-1R is a G-protein coupled receptor that has wide tissue expression, including in the brain, the wall of the portal vein near the hilus of the liver, and arteries and arterioles from various organs (kidney, heart, pancreas, and intestine) [18]

The commercial success of any weight loss therapeutic will depend heavily on patient acceptability and adherence, making oral, long-acting depot, and other non-injectable options critical pipeline priorities rather than nice-to-have features

Since Semaglutide generics are not being manufactured in the USA or Europe at the moment, they can be imported from countries where the Ozempic patent has expired

[PMID: 38355887]

Rules vary by state and federal guidance for controlled substances

Patients are advised to maintain as balanced a diet as possible and to discuss nutritional monitoring with their healthcare team if appetite suppression is marked